Clinical Trial Update: Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study [Phase 4]

View source ↗

Summary

This Phase 4 randomized pilot trial of pioglitazone in obese children with insulin resistance was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Insulin Resistance | Phase 4 | Status: WITHDRAWN